Medpace demonstrates strong financial performance and growth in the CRO market, despite facing challenges in the short term.
IQVIA reaffirms its 2025 outlook, projecting up to $16.13 billion in revenue and EPS of $11.70-$12.10. Strong TAS growth and ...
Q4 2024 Earnings Call Transcript February 6, 2025 IQVIA Holdings Inc. beats earnings expectations. Reported EPS is $3.12, ...
Bank of America Securities analyst Michael Ryskin maintained a Buy rating on IQVIA Holdings (IQV – Research Report) today. The company’s shares ...
Ari Bousbib; Chairman of the Board, Chief Executive Officer; IQVIA Holdings Inc Ronald Bruehlman; Chief Financial Officer, Executive Vice President; IQVIA Holdings Inc Shlomo Rosenbaum; Analyst; ...
Deutsche Bank raised the firm’s price target on Iqvia (IQV) to $260 from $250 and keeps a Buy rating on the shares following the “solid” Q4 ...
Contract research firm IQVIA Holdings beat Wall Street estimates for fourth-quarter profit and revenue on Thursday, helped by the demand for its healthcare data and analytics services.
As you can see below, IQVIA Holdings had US$13.6b of debt, at September 2024, which is about the same as the year before. You can click the chart for greater detail. However, because it has a cash ...
Q4 2024 Management View CEO Ari Bousbib highlighted that IQVIA achieved solid revenue growth of 5.5% at constant currency for the full year, excluding COVID-related revenues. Adjusted diluted EPS ...
IQVIA Holdings Inc. engages in the provision of advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia ...
Nvidia is making an ambitious leap into leveraging AI and accelerated computing to transform healthcare solutions. Surbhi Jain Elliott Investment Management Adds To Southwest, Western Digital ...
He specializes in developing innovative solutions for complex healthcare challenges while enhancing organizational leadership ... including Bristol-Myers Squibb, IQVIA, and Organon, Voll has ...